Eledon Pharmaceuticals (ELDN) Interest & Investment Income (2014 - 2024)

Eledon Pharmaceuticals (ELDN) posted Interest & Investment Income of $102000.0 for Q3 2024, up 292.31% on a QoQ basis from $26000.0 in Q1 2017.

Eledon Pharmaceuticals (ELDN) Interest & Investment Income (2014 - 2024) Analysis & Trends

Eledon Pharmaceuticals' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $102000.0 for Q3 2024.

Quarterly Interest & Investment Income changed N/A year-over-year to $102000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $189000.0 (changed N/A YoY) and the FY2025 annual result came in at -$2000.0, changed N/A from the prior year.
Interest & Investment Income was $102000.0 for Q3 2024 at Eledon Pharmaceuticals, up from $26000.0 in the prior quarter.
Across five years, Interest & Investment Income topped out at $102000.0 in Q3 2024 and bottomed at $102000.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	27.66 Mn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	114.80 Mn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	-65.80 Mn
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	48.00 Mn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	19.51 Mn
10	Eledon Pharmaceuticals	399.11 Mn	399.11 Mn	-	-

Download Data